Zietman A L, Suit H D, Ramsay J R, Silobrcic V, Sedlacek R S
Edwin L. Steele Laboratory for Radiation Biology, Department of Radiation Medicine, Massachusetts General Hospital, Harvard Medical School 02114.
Cancer Res. 1988 Nov 15;48(22):6510-6.
The transplantability of experimental tumors into the brain (i.c.) and s.c. tissues of C3Hf/Sed and athymic NCr/Sed nude mice was examined using quantitative cell transplantation assays. Studies using the immune-competent C3H animals showed that brain is a more favorable site for the transplantation of syngeneic tumor than s.c. tissue and that this is true for nonimmunogenic as well as immunogenic tumors. The capacity of the brain to act as an immunological sanctuary can be overwhelmed by a strong, systemic, secondary immune response such as that evoked by the methylcholanthrene-induced sarcoma FSal. In studies performed using NCr/Sed nude mice, the allogeneic tumor MCaIV was found not to be demonstrably immunogenic. The cell dose required to transplant the tumor into 50% of recipients (TD50) could neither be increased by immunization procedures nor decreased by six Gy whole-body irradiation (WBI) prior to transplantation. Delayed-type hypersensitivity to this tumor was not expressed by nude mice after rechallenge with tumor antigen. The TD50 was again lower for i.c. than s.c. transplantation and the ratio s.c./i.c. was comparable to that found in syngeneic C3Hf/Sed hosts. Three human tumors have been similarly tested. They were: FaDu, a pharyngeal squamous carcinoma; HFSal, a fibrosarcoma; and U87, a malignant glioma. s.c. TD50 values were in all cases significantly higher than those obtained i.c. The ratios TD50 s.c./i.c. ranged from 6.4 to greater than 50 in five studies, substantially higher than those found for transplantation of murine tumors into either the syngeneic or the allogeneic recipients. Six Gy WBI reduced the s.c. TD50 for these tumors, but in each case the value remained significantly higher than that obtained i.c. 19.4 Gy WBI given in 10 equal fractions and followed by i.v. bone marrow rescue reduced further the s.c. TD50 for FaDu. NCr/Sed nude mice demonstrated cross-reacting delayed-type hypersensitivity against FaDu and HFSal. A small proportion of FaDu tumors (less than 2%) displayed a spontaneous halt in growth or even regression. When the host cell infiltrate of these tumors was analyzed, an increase was seen in the proportion of Thy 1.2 and asialo-GM1-positive cells as compared with progressively growing tumors. These data strongly suggest that a residual low level of immune reactivity exists in nude mice against xenotransplanted human tumors. This resistance to s.c. transplantation may be diminished by WBI and is less for intracerebral implantation.
使用定量细胞移植分析方法检测了实验肿瘤在C3Hf/Sed和无胸腺NCr/Sed裸鼠的脑内(i.c.)和皮下(s.c.)组织中的可移植性。使用具有免疫活性的C3H动物进行的研究表明,对于同基因肿瘤移植而言,脑是比皮下组织更有利的部位并且对于非免疫原性和免疫原性肿瘤都是如此。脑作为免疫庇护所的能力可能会被强烈的全身性二次免疫反应(诸如由甲基胆蒽诱导的肉瘤FSal所引发的反应)所压倒。在使用NCr/Sed裸鼠进行的研究中,发现同种异体肿瘤MCaIV没有明显的免疫原性。将肿瘤移植到50%受体所需的细胞剂量(TD50)既不能通过免疫程序增加,也不能通过移植前6 Gy的全身照射(WBI)降低。用肿瘤抗原再次攻击后,裸鼠对该肿瘤未表现出迟发型超敏反应。脑内移植的TD50再次低于皮下移植,并且皮下/脑内的比例与在同基因C3Hf/Sed宿主中发现的比例相当。对三种人类肿瘤进行了类似的检测。它们分别是:FaDu,一种咽鳞状细胞癌;HFSal,一种纤维肉瘤;以及U87,一种恶性胶质瘤。在所有情况下,皮下TD50值均显著高于脑内移植获得的值。在五项研究中,皮下TD50/脑内TD50的比例范围为6.4至大于50,大大高于将鼠类肿瘤移植到同基因或同种异体受体中所发现的比例。6 Gy的WBI降低了这些肿瘤的皮下TD50,但在每种情况下该值仍显著高于脑内移植获得的值。以10个相等剂量给予19.4 Gy的WBI并随后进行静脉内骨髓救援进一步降低了FaDu的皮下TD50。NCr/Sed裸鼠对FaDu和HFSal表现出交叉反应性迟发型超敏反应。一小部分FaDu肿瘤(小于2%)出现生长自发停滞甚至消退。当分析这些肿瘤的宿主细胞浸润情况时,与逐渐生长的肿瘤相比,Thy 1.2和去唾液酸GM1阳性细胞的比例有所增加。这些数据强烈表明,裸鼠对异种移植的人类肿瘤存在残留的低水平免疫反应性。这种对皮下移植的抗性可能会被WBI减弱,并且对于脑内植入而言抗性较小。